2021New England Journal of MedicineRequires access

Intranasal Naloxone Administration

Rafael Ortega, Ala Nozari, William E. Baker, Sannoor Surani, Melinda Edwards

Open publisher page 11 citations

Abstract

Intranasal naloxone is used to treat patients with respiratory and central nervous system depression that is known or suspected to be caused by an opioid overdose. This video demonstrates the administration of intranasal naloxone.

About this research paper

What this paper is about

Intranasal naloxone is used to treat patients with respiratory and central nervous system depression that is known or suspected to be caused by an opioid overdose. This video demonstrates the administration of intranasal naloxone.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Intranasal naloxone is used to treat patients with respiratory and central nervous system depression that is known or suspected to be caused by an opioid overdose. This video demonstrates the administration of intranasal naloxone.

Key concepts: Nasal administration, (+)-Naloxone, Medicine, Anesthesia, Opioid overdose, Opioid, Administration (probate law), Depression (economics)

Related papers

Back to paper searchBrowse research topicsOriginal source
Intranasal Naloxone Administration — Research Paper | ScholarLens